v3.25.1
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (5,484) $ (13,015)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 986 1,102
Amortization of right-of-use assets 129 170
Amortization of costs to obtain contracts 22 22
Amortization of costs to fulfill contracts 62 12
Amortization of debt issuance costs 177 152
Stock-based compensation 538 718
Bad debt expense   143
Foreign currency loss (gain) 25 (35)
Interest receivable (24) (257)
Loss on debt extinguishment   1,405
Loss on disposal of property, equipment and software   22
Change in fair value of contingent consideration and derivative liabilities (114) (821)
Noncash interest expense 538 1,921
Paid-in-kind interest capitalized 1,600  
Income from equity method investment (150)  
Changes in operating assets and liabilities:    
Accounts receivable (616) 8,041
Prepaid expenses and other current assets 745 1,142
Other assets (148) (183)
Accounts payable 258 (404)
Accrued expenses (4,509) 2,732
Deferred revenue (8) (72)
Lease liabilities (135) (188)
Long-term liabilities 942 (12,319)
Net cash used in operating activities (5,166) (9,712)
Cash flows from investing activities:    
Purchases of property, equipment and software (65) (73)
Investment in capitalized software (1,137) (1,315)
Proceeds from short-term deposits and sale of marketable securities   25,117
Net cash provided by (used in) investing activities (1,202) 23,729
Cash flows from financing activities:    
Repayment of term loan (10,000) (17,500)
Payments of debt issuance costs (2,293) (566)
Proceeds from revolving credit facility 20,410  
Payments on revolving credit facility (9,518)  
Net cash used in financing activities (1,401) (18,066)
Effect of exchange rate changes on cash, cash equivalents and restricted cash   35
Net decrease in cash, cash equivalents and restricted cash (7,769) (4,014)
Cash, cash equivalents and restricted cash, beginning of period 14,179 38,256
Cash, cash equivalents and restricted cash, end of period 6,410 34,242
Supplemental disclosure of cash flow information:    
Cash paid for interest 278 1,969
Cash paid for income taxes 52 $ 119
Supplemental noncash investing and financing activities:    
Issuance of common stock in connection with term loan amendment 570  
Derivative liability resulting from term loan amendment $ 508